摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-羟基四氢硫代吡喃 | 22072-19-1

中文名称
3-羟基四氢硫代吡喃
中文别名
——
英文名称
thiacyclohexan-3-ol
英文别名
3-hydroxytetrahydrothiopyran;thian-3-ol
3-羟基四氢硫代吡喃化学式
CAS
22072-19-1
化学式
C5H10OS
mdl
——
分子量
118.2
InChiKey
ZHHOMIAGFRSWCU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    13-15 °C
  • 沸点:
    152.48°C (estimate)
  • 密度:
    1.1400
  • LogP:
    0.936 (est)

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    7
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    45.5
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 安全说明:
    S24/25
  • 海关编码:
    2934999090

SDS

SDS:82d9dbaf46b1cf093e9e7f74cd7ca0ac
查看
Name: Tetrahydrothiopyran-3-ol 95% Material Safety Data Sheet
Synonym:
CAS: 22072-19-1
Section 1 - Chemical Product MSDS Name:Tetrahydrothiopyran-3-ol 95% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
22072-19-1 Tetrahydrothiopyran-3-ol, 95% 95% 244-766-6
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid if cough or other symptoms appear.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 22072-19-1: Personal Protective Equipment Eyes: Wear chemical splash goggles.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear a chemical apron.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: Clear
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.1480g/cm3
Molecular Formula: C5H10O5
Molecular Weight: 118.19

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Not available.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 22072-19-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Tetrahydrothiopyran-3-ol, 95% - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 22072-19-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 22072-19-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 22072-19-1 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-羟基四氢硫代吡喃草酰氯二甲基亚砜三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 1.5h, 以45%的产率得到二氢-2H-硫代吡喃-3(4h)-酮
    参考文献:
    名称:
    WO2008/147314
    摘要:
    公开号:
  • 作为产物:
    描述:
    二氢-2H-硫代吡喃-3(4h)-酮盐酸 、 sodium borohydrid 作用下, 以 乙醇 为溶剂, 生成 3-羟基四氢硫代吡喃
    参考文献:
    名称:
    Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines,
    摘要:
    描述了一种新型的替代硫杂环烯[3,2-b]吡啶类化合物。这些化合物可作为钙通道拮抗剂,具有心血管、抗哮喘和抗支气管收缩活性。
    公开号:
    US04777167A1
点击查看最新优质反应信息

文献信息

  • Iron-Catalyzed α-Alkylation of Ketones with Secondary Alcohols: Access to β-Disubstituted Carbonyl Compounds
    作者:Léo Bettoni、Sylvain Gaillard、Jean-Luc Renaud
    DOI:10.1021/acs.orglett.0c00549
    日期:2020.3.6
    borrowing hydrogen strategy has been applied in the synthesis of β-branched carbonyl compounds. Various secondary benzylic and aliphatic alcohols have been used as alkylating reagents under mild reaction conditions. The ketones have been isolated in good to excellent yield. Deuterium labeling experiments provide evidence that the alcohol is the hydride source in this reaction and that no reversible step or
    铁催化的借位氢策略已用于合成β-支链羰基化合物。在温和的反应条件下,各种仲苄醇和脂族醇已被用作烷基化试剂。酮以良好至极好的收率被分离出来。氘标记实验提供了证据,表明醇是该反应中的氢化物来源,并且在此过程中未发生可逆步骤或氢/氘加扰。
  • 2-alkylthiopenem derivatives
    申请人:Pfizer Inc.
    公开号:US04619924A1
    公开(公告)日:1986-10-28
    Certain 2-alkylthio-2-penem-3-carboxylic acid compounds are useful as antibacterials for treating mammals.
    某些2-烷基硫代-2-佩内姆-3-羧酸化合物可用作治疗哺乳动物的抗菌剂。
  • Herbicidal 1,2,4,6-thiatriazines
    申请人:Syngenta Investment Corporation
    公开号:US06362134B1
    公开(公告)日:2002-03-26
    Compounds of formula (I), in which R1, R2 and R3 are as defined in claim 1, are particularly suitable as herbicides.
    式(I)中的化合物,其中R1、R2和R3如权利要求1所定义,特别适用作为除草剂。
  • Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines,
    申请人:Ortho Pharmaceutical Corporation
    公开号:US04777167A1
    公开(公告)日:1988-10-11
    Novel substituted thiacycloalkeno [3,2-b]pyridines are described. These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstrictor activity.
    描述了一种新型的替代硫杂环烯[3,2-b]吡啶类化合物。这些化合物可作为钙通道拮抗剂,具有心血管、抗哮喘和抗支气管收缩活性。
  • Novel compounds
    申请人:——
    公开号:US20040242573A1
    公开(公告)日:2004-12-02
    The invention relates to thiophene carboxanmides of formula (I). wherein A, R 1 , R 2 , R 3 , n and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy. 1
    本发明涉及公式(I)的噻吩羧酰胺,其中A,R1,R2,R3,n和X如规范中定义的,以及用于其制备的工艺和中间体,含有它们的制药组合物以及它们在治疗中的使用。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
mass
cnmr
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

阿普卡林 硫化环戊烷 硫代环己酮 甲基(1,1-二氧化四氢-2h-噻喃-4-基)醋酸盐 四氢硫代吡喃-4-胺盐酸盐 四氢硫代吡喃-4-羰酰氯 四氢硫代吡喃-4-羧酸甲酯 四氢硫代吡喃-4-甲腈 四氢硫代吡喃-4-基甲醇 四氢硫代吡喃-3-甲醛 四氢噻喃-4-醇 四氢噻喃-4-酮肟 四氢噻喃-4-酮 1,1-二氧化物 四氢噻喃-4-酮 四氢噻喃-4-胺 四氢噻喃-4-肼双盐酸盐 四氢噻喃-4-甲醛 四氢-4H-硫代吡喃-4-酮 1-氧化物 四氢-4-氧代-2H-噻喃-3-甲酸甲酯 四氢-3-甲基-2H-噻喃 四氢-3-氧代-6H-噻喃-2-甲酸甲酯 四氢-2H-硫代吡喃-4-醇 1,1-二氧化物 四氢-2H-硫代吡喃-4-羧醛 1,1-二氧化物 四氢-2H-硫代吡喃-4-甲醇 1,1-二氧化物 四氢-2H-硫代吡喃-4-乙醛 四氢-2H-噻喃-4-羧酸甲酯1,1-二氧化物 四氢-2H-噻喃-4-甲酰肼 四氢-2H-噻喃-4-甲腈1,1-二氧化 四氢-2H-噻喃-3-醇1,1-二氧化物 四氢-2H-噻喃-3-羧酸1,1-二氧化物 四氢-(9ci)-2H-硫代吡喃-4-羧酸 噻-4-基甲胺 叔-丁基[(1S,2R)-1-苯甲基-2-羟基-3-[异丁基[(4-硝基苯基)磺酰]氨基]丙基]氨基甲酸酯 二氢-5,5-二甲基-2H-硫基吡喃-3(4H)-酮-1,1-二氧化物 二氢-2H-硫代吡喃-3(4h)-酮 二氢-2H-硫代吡喃-3(4H)-酮-1,1-二氧化物 乙酸四氢-2H-噻喃-2-基酯 n-[四氢-2H-硫代吡喃-4-基]氨基甲酸-1,1-二甲基乙酯 N-甲基四氢-2H-硫代吡喃-4-胺盐酸盐 N-甲基四氢-2H-噻喃-4-胺盐酸盐 N-甲基(四氢硫代吡喃-4-基)甲基胺 9-硫杂二环[3.3.1]壬烷-2,6-二酮 9-硫杂二环[3.3.1]壬烷 8-硫杂二环[3.2.1]辛烷-3-酮 8-硫杂-2,3-二氮杂螺[4.5]癸烷 7-硫杂-2-氮杂螺[3.5]壬烷半草酸酯 7-硫杂-2-氮杂螺[3.5]壬烷7,7-二氧化物 6-氧代四氢-2H-噻喃-2-羧酸 5-硫代-alpha-D-吡喃葡萄糖 5-硫代-alpha-D-吡喃葡萄糖